- CytoDyn CEO Dr. Pourhassan Appearance on Fox Business Network Rescheduled to April 8 Same Time (11am PT); CytoDyn will Reveal Today the Name of the Hospital and the Physician who Treated 10 Patients During an Interview on Seattle-Affiliate of CBS News which Will Air Between 5-6:30 p.m. PT
- BioSig to Host Telebriefing on Development Updates Regarding Vicromax(tm), a Novel Broad-Spectrum Anti-Viral Candidate That May Treat COVID-19
- Trxade Featured in Broadcast on Much-Needed Solutions to Healthcare Dilemma
- CytoDyn Files Request with FDA for Preliminary Meeting for Breakthrough Therapy Designation for Leronlimab in the Treatment of Cancer
- CytoDyn CEO Dr. Pourhassan to Appear on Fox Business Network Friday, April 3, 2020 at 2:00 pm ET to Discuss Leronlimab Treatment of 10 Severely Ill COVID-19 Patients and Express Appreciation for a Special Hospital, Physician, and Medical Team Who Treated These Patients
- Immunicum AB (publ) Publishes the Annual Report for 2019
- Immunicum AB (publ) offentliggör årsredovisning för 2019
- Gevo Hires Citigroup to Assist with Financings
- Trxade Spotlighted in Publication Discussing Healthcare Challenge, Solution
- RAPID DOSE THERAPEUTICS DONATES QUICKSTRIPâ„¢ VITAMIN B12 NUTRACEUTICAL PRODUCT TO COMMUNITY
